These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8262690)

  • 1. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease.
    Ceyhan B; Celikel T; Simsir S; Kandemir B
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):510-3. PubMed ID: 8262690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of inhaling pirenzepine--selective M1 receptor antagonist and ipratropium bromide on lung ventilation in patients with bronchial asthma].
    Krasnowska M; Jankowska R; Jagiełło E
    Pneumonol Alergol Pol; 1994; 62(11-12):609-14. PubMed ID: 7719260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
    Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
    Dor A; Krasnowska M; Małolepszy J
    Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease.
    Rodríguez-Carballeira M; Heredia JL; Gomez L; Quintana S; Vinas C
    Pulm Pharmacol Ther; 1999; 12(1):43-8. PubMed ID: 10447370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J; Díaz O; Lisboa C
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.
    Sposato B; Barzan R; Calabrese A; Franco C
    J Asthma; 2008 Jun; 45(5):397-401. PubMed ID: 18569233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to the administration of corticosteroids in patients with chronic obstructive lung disease and asthma].
    Barbas Filho JV; Barbas CS; de Carvalho CR; Godoy R; Vianna Edos S; Lorenzi Filho G
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):159-62. PubMed ID: 1843711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
    Salo D; Tuel M; Lavery RF; Reischel U; Lebowitz J; Moore T
    J Emerg Med; 2006 Nov; 31(4):371-6. PubMed ID: 17046476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heliox and forward-leaning posture improve the efficacy of nebulized bronchodilator in acute asthma: a randomized trial.
    Brandão DC; Britto MC; Pessoa MF; de Sá RB; Alcoforado L; Matos LO; Silva TN; de Andrade AD
    Respir Care; 2011 Jul; 56(7):947-52. PubMed ID: 21352660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.